摘要:
The present invention is directed to novel quinoline-3-carbonitriles according to Formula I, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof. The compounds and compositions of the present invention have protein kinases inhibitory activities and are useful for the treatment of protein kinases mediated diseases and conditions.
摘要:
This disclosure discloses an apparatus of treating a black and odorous river, comprising a river bed sludge suction device, a container-type sand-stone refuse separation device, a container-type dehydration device, a container-type pulverization device, a storage container, a container-type drying device, a container-type carbonization device, a container-type flocculation device, a container-type precipitation device, a container-type activated coke filtration and adsorption device, a container-type power generation device, a container-type operation and control chamber, and a cleaning ship for river surface floats and river bank refuse. This disclosure discloses a method of treating a river using the apparatus described above where a biochar is produced from the separated, dehydrated and dried sludge. The biochar is then delivered back to the river bed to absorb nitrogen and phosphorus, cleaning the river water, followed by purification treatments on sewage discharged from the dehydration apparatus and discharging the treated sewage water back to the river.
摘要:
There is provided an active coke regeneration mixed vapor treatment method. The method comprises the following process steps of: A) performing a first water condensation on a mixed vapor produced during an active coke regeneration process by spray water in a first condensation zone; B) performing a second water condensation on the mixed vapor that is after the first water condensation by spray water in a second condensation zone, to further condensate and purify the mixed vapor; C) eliminating moisture in a gas through mist elimination from the gas fraction in the mixed vapor that is after the second water condensation, and discharging the remaining gas from the upper of the second condensation zone; and, D) discharging active coke micro powder in the mixed vapor that is after the second water condensation, with condensation water. In the present invention, an apparatus for implementing the abovementioned method is also provided.
摘要:
The invention provides an electrically conductive and optically transparent copper-reduced graphene oxide core-shell nanowires film and its specific application for light transmission controlling devices.
摘要:
The present invention is directed to novel quinolines and quniazolines, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R1 to R11 and X are defined herein.
摘要:
Substituted bicyclic heteroaryls having the structures: and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
摘要:
The present invention is directed to novel ureas, their derivatives, pharmaceutically acceptable salts, solvates and hydrates thereof which are useful for the treatment of protein kinases mediated diseases and conditions. The compounds of this invention have a general Formula (I) wherein R, R1 to R10 are defined herein.
摘要:
The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I wherein A, B, R1, R2, R3 and R4 are defined herein. The invention also comprises pharmaceutical compositions including one or more compounds of Formula I, uses of such compounds and compositions for treatment of P38 map kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders, as well as intermediates and processes useful for the preparation of compounds of Formula I.
摘要:
Wastewater and sewage filtering and adsorbing unit includes sewage reservoir, clean water reservoir, active coke powder storage, filtering and adsorbing tank, control cabinet, saturated active coke sludge settling tank, filtering and adsorbing material. The sewage reservoir and the clean water reservoir are on one side, and the filtering and adsorbing tank and the active coke powder storage are on other side. Active coke powder storage is above and connected to filtering and adsorbing tank by conduits; inlet pipes in rows and an outlet branch pipe are mounted into the filtering and adsorbing tank. Filtering and adsorbing material is active coke powder. The sewage reservoir is connected with the filtering and adsorbing tank. An active coke sludge discharge port and an active coke sludge conveyor, which are connected to the saturated active coke sludge settling tank by transporting pipelines, are at the bottom of the filtering and adsorbing tank.
摘要:
A method for treating saturated activated coke comprises the following steps: A) The saturated activated coke is subjected to a dehydration treatment so that the water content in the activated coke is ≦25%; B) The product obtained from step A is dried at a starting temperature of 120° C.-150° C.; C) The product obtained from step B is subjected to dry distillation and the condition of the dry distillation is that: by heating to a final temperature for the drying of 500° C.-600° C. at a speed of 4° C.-10° C./min and maintaining for 10-60 minutes, the organics adsorbed on the surface and in the pores of the activated coke is cracked, volatilized and carbonized; D) The product obtained from step C is activated and the activation condition is that: after heating to 800° C.-950° C. at 2° C.-8° C./min, a stream is supplied, wherein the weight ratio of the activated coke to the stream is 1:0.5-5 and the activation time is 0.5-2 h. The activated coke after several times of treatment can be used as the fuel.